Welcome to ATMP Sweden!
ATMP Sweden is the national network of Sweden’s activities within medicines based on genes, cells or tissue engineering, classified as Advanced Therapy Medicinal Products (ATMPs) in Europe. Our goal is to promote the collaboration and communication needed for accelerated, effective ATMP based patient solutions.
Who are we?
The ATMP Sweden network was founded through the Vinnova funded projects CAMP and Swelife-ATMP. The activity is now supported by the Vinnova funded ATMP Innovation Milieu. Other Swedish ATMP specific or relevant national networks fit under the ATMP Sweden umbrella including NextGenNK, GenNova, IndiCell and SWECARNET. ATMP Sweden provides support in communication, collaboration and network building. Learn more about these and other ATMP relevant initiatives!
Resources
Learn more about the Health Technology Assessment related issues of your ATMP development.
This guide will provide useful information and insights throughout the ATMP development process.
Find or advertise ATMP relevant job opportunities.
What are ATMPs?
News
2021-10-19
Sweden invests in innovation hub for advanced therapies
Enabling industrial scale production of mRNA and DNA based ATMPs and vaccines
Read article
2021-10-14
From Swedish cellulose to global medical innovation
Sweden’s BICO drives better and more accessible healthcare worldwide
Read article
Conferences & events
Conference
ATMP Sweden 2021
16 November
Online
Organizer: ATMP Sweden
Learnings from 'gene delivery' COVID vaccines relevant to ATMP
Read moreCourse
INTRODUCTION TO ATMP COURSE
22 November
Online
Organizer: ATMP Innovation Milieu
AVAILABLE from the 9th of June 2021! Learn the basics of Advanced Therapy Medicinal Products.
Read moreSeminar
ATMP-centra – varför, hur och var?
23 November
ZOOM
Organizer: ATMP Innovation Milieu
ATMP-centra som växer fram vid sjukhus och universitet på allt fler platser i Sverige
Read more